(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.
IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executive director. Says he will succeed outgoing Chair D...
Fund:
Marshall Wace Llp
% Short:
0.69%
Date Changed:
24-Apr-26